Tivic Health Systems Q4 2025 Earnings Call Recap: CEO Michael Handley Outlines Transformation Plan

Tivic Health Systems, Inc. reported its FY 2025 financial results, with a focus on strategic transformation. The company completed a pivot to a high-impact immunotherapy company, with a goal of saving lives and delivering long-term value to shareholders. The CEO, Michael Handley, emphasized the importance of evolving the company and advancing critical therapies to patients. The CFO, Lisa Wolf, will provide further details on the financial results.